The value of medicines prescribed to patients in Romania in the October 2022-September 2023 period reached RON28.7 billion (EUR5.8 billion) at wholesale prices, up 16% from the year-earlier period, in line with Cegedim data.
Aquila, the market leader in the field of integrated distribution and logistics services for consumer goods in Romania and the Republic of Moldova, ended the first nine months of 2023 with RON1.7 billion revenues, up 14% from the year-earlier period, while net profit rose by 9% year-on-year, to RON70 million.
Nuclearelectrica, Romania’s sole nuclear energy producer, reported net profit of almost RON2 billion in the first nine months of 2023, up 1.9% from the year-earlier period, while revenues climbed by 15% to RON5.67 billion. The results came amid 2.9% higher energy output.
OTP Bank Romania in the first nine months of 2023 posted RON236 million consolidated net profit.